Antianginal Agents Market, Global Outlook and Forecast 2022-2028
Antianginal agents is a term used to describe a wide variety of medicines that are used in the management of angina.
This report contains market size and forecasts of Antianginal Agents in global, including the following market information:
Global Antianginal Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antianginal Agents Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antianginal Agents companies in 2021 (%)
The global Antianginal Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nitrates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antianginal Agents include Teva, Merck, Pfizer, Mylan N.V., Elite Pharmaceutical Solution Inc., Pharmaoffer.com, AstraZeneca, ACETO and Nesher Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antianginal Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antianginal Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antianginal Agents Market Segment Percentages, by Type, 2021 (%)
Global Antianginal Agents Market Segment Percentages, by Distribution Channel, 2021 (%)
Global Antianginal Agents Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Antianginal Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antianginal Agents revenues share in global market, 2021 (%)
Key companies Antianginal Agents sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Antianginal Agents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Antianginal Agents in global, including the following market information:
Global Antianginal Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antianginal Agents Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antianginal Agents companies in 2021 (%)
The global Antianginal Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nitrates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antianginal Agents include Teva, Merck, Pfizer, Mylan N.V., Elite Pharmaceutical Solution Inc., Pharmaoffer.com, AstraZeneca, ACETO and Nesher Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antianginal Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antianginal Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antianginal Agents Market Segment Percentages, by Type, 2021 (%)
- Nitrates
- Beta Blockers
- Calcium Channel Blockers
Global Antianginal Agents Market Segment Percentages, by Distribution Channel, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Antianginal Agents Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Antianginal Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antianginal Agents revenues share in global market, 2021 (%)
Key companies Antianginal Agents sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Antianginal Agents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teva
- Merck
- Pfizer
- Mylan N.V.
- Elite Pharmaceutical Solution Inc.
- Pharmaoffer.com
- AstraZeneca
- ACETO
- Nesher Pharmaceuticals
- Taj pharmaceutical
- Espero BioPharma
- Hikma Pharmaceuticals
- Athenex
- Aurobindo Pharma
- AMRI
- Intas Pharmaceuticals
- Glenmark Pharmaceuticals
- Troikaa
- Square Pharmaceuticals
- Sun Pharmaceutical
- Unique Pharmaceuticals
- Ipca Laboratories
- Sandoz
- Globus Remedies
- Shandong Fangming Pharmaceutical Group
- ReYoung Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Antianginal Agents Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Distribution Channel
1.3 Global Antianginal Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIANGINAL AGENTS OVERALL MARKET SIZE
2.1 Global Antianginal Agents Market Size: 2021 VS 2028
2.2 Global Antianginal Agents Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antianginal Agents Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antianginal Agents Players in Global Market
3.2 Top Global Antianginal Agents Companies Ranked by Revenue
3.3 Global Antianginal Agents Revenue by Companies
3.4 Global Antianginal Agents Sales by Companies
3.5 Global Antianginal Agents Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antianginal Agents Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antianginal Agents Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antianginal Agents Players in Global Market
3.8.1 List of Global Tier 1 Antianginal Agents Companies
3.8.2 List of Global Tier 2 and Tier 3 Antianginal Agents Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antianginal Agents Market Size Markets, 2021 & 2028
4.1.2 Nitrates
4.1.3 Beta Blockers
4.1.4 Calcium Channel Blockers
4.2 By Type - Global Antianginal Agents Revenue & Forecasts
4.2.1 By Type - Global Antianginal Agents Revenue, 2017-2022
4.2.2 By Type - Global Antianginal Agents Revenue, 2023-2028
4.2.3 By Type - Global Antianginal Agents Revenue Market Share, 2017-2028
4.3 By Type - Global Antianginal Agents Sales & Forecasts
4.3.1 By Type - Global Antianginal Agents Sales, 2017-2022
4.3.2 By Type - Global Antianginal Agents Sales, 2023-2028
4.3.3 By Type - Global Antianginal Agents Sales Market Share, 2017-2028
4.4 By Type - Global Antianginal Agents Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY DISTRIBUTION CHANNEL
5.1 Overview
5.1.1 By Distribution Channel - Global Antianginal Agents Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Distribution Channel - Global Antianginal Agents Revenue & Forecasts
5.2.1 By Distribution Channel - Global Antianginal Agents Revenue, 2017-2022
5.2.2 By Distribution Channel - Global Antianginal Agents Revenue, 2023-2028
5.2.3 By Distribution Channel - Global Antianginal Agents Revenue Market Share, 2017-2028
5.3 By Distribution Channel - Global Antianginal Agents Sales & Forecasts
5.3.1 By Distribution Channel - Global Antianginal Agents Sales, 2017-2022
5.3.2 By Distribution Channel - Global Antianginal Agents Sales, 2023-2028
5.3.3 By Distribution Channel - Global Antianginal Agents Sales Market Share, 2017-2028
5.4 By Distribution Channel - Global Antianginal Agents Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antianginal Agents Market Size, 2021 & 2028
6.2 By Region - Global Antianginal Agents Revenue & Forecasts
6.2.1 By Region - Global Antianginal Agents Revenue, 2017-2022
6.2.2 By Region - Global Antianginal Agents Revenue, 2023-2028
6.2.3 By Region - Global Antianginal Agents Revenue Market Share, 2017-2028
6.3 By Region - Global Antianginal Agents Sales & Forecasts
6.3.1 By Region - Global Antianginal Agents Sales, 2017-2022
6.3.2 By Region - Global Antianginal Agents Sales, 2023-2028
6.3.3 By Region - Global Antianginal Agents Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antianginal Agents Revenue, 2017-2028
6.4.2 By Country - North America Antianginal Agents Sales, 2017-2028
6.4.3 US Antianginal Agents Market Size, 2017-2028
6.4.4 Canada Antianginal Agents Market Size, 2017-2028
6.4.5 Mexico Antianginal Agents Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antianginal Agents Revenue, 2017-2028
6.5.2 By Country - Europe Antianginal Agents Sales, 2017-2028
6.5.3 Germany Antianginal Agents Market Size, 2017-2028
6.5.4 France Antianginal Agents Market Size, 2017-2028
6.5.5 U.K. Antianginal Agents Market Size, 2017-2028
6.5.6 Italy Antianginal Agents Market Size, 2017-2028
6.5.7 Russia Antianginal Agents Market Size, 2017-2028
6.5.8 Nordic Countries Antianginal Agents Market Size, 2017-2028
6.5.9 Benelux Antianginal Agents Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antianginal Agents Revenue, 2017-2028
6.6.2 By Region - Asia Antianginal Agents Sales, 2017-2028
6.6.3 China Antianginal Agents Market Size, 2017-2028
6.6.4 Japan Antianginal Agents Market Size, 2017-2028
6.6.5 South Korea Antianginal Agents Market Size, 2017-2028
6.6.6 Southeast Asia Antianginal Agents Market Size, 2017-2028
6.6.7 India Antianginal Agents Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antianginal Agents Revenue, 2017-2028
6.7.2 By Country - South America Antianginal Agents Sales, 2017-2028
6.7.3 Brazil Antianginal Agents Market Size, 2017-2028
6.7.4 Argentina Antianginal Agents Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antianginal Agents Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antianginal Agents Sales, 2017-2028
6.8.3 Turkey Antianginal Agents Market Size, 2017-2028
6.8.4 Israel Antianginal Agents Market Size, 2017-2028
6.8.5 Saudi Arabia Antianginal Agents Market Size, 2017-2028
6.8.6 UAE Antianginal Agents Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Antianginal Agents Major Product Offerings
7.1.4 Teva Antianginal Agents Sales and Revenue in Global (2017-2022)
7.1.5 Teva Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Antianginal Agents Major Product Offerings
7.2.4 Merck Antianginal Agents Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Antianginal Agents Major Product Offerings
7.3.4 Pfizer Antianginal Agents Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Mylan N.V.
7.4.1 Mylan N.V. Corporate Summary
7.4.2 Mylan N.V. Business Overview
7.4.3 Mylan N.V. Antianginal Agents Major Product Offerings
7.4.4 Mylan N.V. Antianginal Agents Sales and Revenue in Global (2017-2022)
7.4.5 Mylan N.V. Key News
7.5 Elite Pharmaceutical Solution Inc.
7.5.1 Elite Pharmaceutical Solution Inc. Corporate Summary
7.5.2 Elite Pharmaceutical Solution Inc. Business Overview
7.5.3 Elite Pharmaceutical Solution Inc. Antianginal Agents Major Product Offerings
7.5.4 Elite Pharmaceutical Solution Inc. Antianginal Agents Sales and Revenue in Global (2017-2022)
7.5.5 Elite Pharmaceutical Solution Inc. Key News
7.6 Pharmaoffer.com
7.6.1 Pharmaoffer.com Corporate Summary
7.6.2 Pharmaoffer.com Business Overview
7.6.3 Pharmaoffer.com Antianginal Agents Major Product Offerings
7.6.4 Pharmaoffer.com Antianginal Agents Sales and Revenue in Global (2017-2022)
7.6.5 Pharmaoffer.com Key News
7.7 AstraZeneca
7.7.1 AstraZeneca Corporate Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Antianginal Agents Major Product Offerings
7.7.4 AstraZeneca Antianginal Agents Sales and Revenue in Global (2017-2022)
7.7.5 AstraZeneca Key News
7.8 ACETO
7.8.1 ACETO Corporate Summary
7.8.2 ACETO Business Overview
7.8.3 ACETO Antianginal Agents Major Product Offerings
7.8.4 ACETO Antianginal Agents Sales and Revenue in Global (2017-2022)
7.8.5 ACETO Key News
7.9 Nesher Pharmaceuticals
7.9.1 Nesher Pharmaceuticals Corporate Summary
7.9.2 Nesher Pharmaceuticals Business Overview
7.9.3 Nesher Pharmaceuticals Antianginal Agents Major Product Offerings
7.9.4 Nesher Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.9.5 Nesher Pharmaceuticals Key News
7.10 Taj pharmaceutical
7.10.1 Taj pharmaceutical Corporate Summary
7.10.2 Taj pharmaceutical Business Overview
7.10.3 Taj pharmaceutical Antianginal Agents Major Product Offerings
7.10.4 Taj pharmaceutical Antianginal Agents Sales and Revenue in Global (2017-2022)
7.10.5 Taj pharmaceutical Key News
7.11 Espero BioPharma
7.11.1 Espero BioPharma Corporate Summary
7.11.2 Espero BioPharma Antianginal Agents Business Overview
7.11.3 Espero BioPharma Antianginal Agents Major Product Offerings
7.11.4 Espero BioPharma Antianginal Agents Sales and Revenue in Global (2017-2022)
7.11.5 Espero BioPharma Key News
7.12 Hikma Pharmaceuticals
7.12.1 Hikma Pharmaceuticals Corporate Summary
7.12.2 Hikma Pharmaceuticals Antianginal Agents Business Overview
7.12.3 Hikma Pharmaceuticals Antianginal Agents Major Product Offerings
7.12.4 Hikma Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.12.5 Hikma Pharmaceuticals Key News
7.13 Athenex
7.13.1 Athenex Corporate Summary
7.13.2 Athenex Antianginal Agents Business Overview
7.13.3 Athenex Antianginal Agents Major Product Offerings
7.13.4 Athenex Antianginal Agents Sales and Revenue in Global (2017-2022)
7.13.5 Athenex Key News
7.14 Aurobindo Pharma
7.14.1 Aurobindo Pharma Corporate Summary
7.14.2 Aurobindo Pharma Business Overview
7.14.3 Aurobindo Pharma Antianginal Agents Major Product Offerings
7.14.4 Aurobindo Pharma Antianginal Agents Sales and Revenue in Global (2017-2022)
7.14.5 Aurobindo Pharma Key News
7.15 AMRI
7.15.1 AMRI Corporate Summary
7.15.2 AMRI Business Overview
7.15.3 AMRI Antianginal Agents Major Product Offerings
7.15.4 AMRI Antianginal Agents Sales and Revenue in Global (2017-2022)
7.15.5 AMRI Key News
7.16 Intas Pharmaceuticals
7.16.1 Intas Pharmaceuticals Corporate Summary
7.16.2 Intas Pharmaceuticals Business Overview
7.16.3 Intas Pharmaceuticals Antianginal Agents Major Product Offerings
7.16.4 Intas Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.16.5 Intas Pharmaceuticals Key News
7.17 Glenmark Pharmaceuticals
7.17.1 Glenmark Pharmaceuticals Corporate Summary
7.17.2 Glenmark Pharmaceuticals Business Overview
7.17.3 Glenmark Pharmaceuticals Antianginal Agents Major Product Offerings
7.17.4 Glenmark Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.17.5 Glenmark Pharmaceuticals Key News
7.18 Troikaa
7.18.1 Troikaa Corporate Summary
7.18.2 Troikaa Business Overview
7.18.3 Troikaa Antianginal Agents Major Product Offerings
7.18.4 Troikaa Antianginal Agents Sales and Revenue in Global (2017-2022)
7.18.5 Troikaa Key News
7.19 Square Pharmaceuticals
7.19.1 Square Pharmaceuticals Corporate Summary
7.19.2 Square Pharmaceuticals Business Overview
7.19.3 Square Pharmaceuticals Antianginal Agents Major Product Offerings
7.19.4 Square Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.19.5 Square Pharmaceuticals Key News
7.20 Sun Pharmaceutical
7.20.1 Sun Pharmaceutical Corporate Summary
7.20.2 Sun Pharmaceutical Business Overview
7.20.3 Sun Pharmaceutical Antianginal Agents Major Product Offerings
7.20.4 Sun Pharmaceutical Antianginal Agents Sales and Revenue in Global (2017-2022)
7.20.5 Sun Pharmaceutical Key News
7.21 Unique Pharmaceuticals
7.21.1 Unique Pharmaceuticals Corporate Summary
7.21.2 Unique Pharmaceuticals Business Overview
7.21.3 Unique Pharmaceuticals Antianginal Agents Major Product Offerings
7.21.4 Unique Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.21.5 Unique Pharmaceuticals Key News
7.22 Ipca Laboratories
7.22.1 Ipca Laboratories Corporate Summary
7.22.2 Ipca Laboratories Business Overview
7.22.3 Ipca Laboratories Antianginal Agents Major Product Offerings
7.22.4 Ipca Laboratories Antianginal Agents Sales and Revenue in Global (2017-2022)
7.22.5 Ipca Laboratories Key News
7.23 Sandoz
7.23.1 Sandoz Corporate Summary
7.23.2 Sandoz Business Overview
7.23.3 Sandoz Antianginal Agents Major Product Offerings
7.23.4 Sandoz Antianginal Agents Sales and Revenue in Global (2017-2022)
7.23.5 Sandoz Key News
7.24 Globus Remedies
7.24.1 Globus Remedies Corporate Summary
7.24.2 Globus Remedies Business Overview
7.24.3 Globus Remedies Antianginal Agents Major Product Offerings
7.24.4 Globus Remedies Antianginal Agents Sales and Revenue in Global (2017-2022)
7.24.5 Globus Remedies Key News
7.25 Shandong Fangming Pharmaceutical Group
7.25.1 Shandong Fangming Pharmaceutical Group Corporate Summary
7.25.2 Shandong Fangming Pharmaceutical Group Business Overview
7.25.3 Shandong Fangming Pharmaceutical Group Antianginal Agents Major Product Offerings
7.25.4 Shandong Fangming Pharmaceutical Group Antianginal Agents Sales and Revenue in Global (2017-2022)
7.25.5 Shandong Fangming Pharmaceutical Group Key News
7.26 ReYoung Pharmaceutical
7.26.1 ReYoung Pharmaceutical Corporate Summary
7.26.2 ReYoung Pharmaceutical Business Overview
7.26.3 ReYoung Pharmaceutical Antianginal Agents Major Product Offerings
7.26.4 ReYoung Pharmaceutical Antianginal Agents Sales and Revenue in Global (2017-2022)
7.26.5 ReYoung Pharmaceutical Key News
8 GLOBAL ANTIANGINAL AGENTS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antianginal Agents Production Capacity, 2017-2028
8.2 Antianginal Agents Production Capacity of Key Manufacturers in Global Market
8.3 Global Antianginal Agents Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIANGINAL AGENTS SUPPLY CHAIN ANALYSIS
10.1 Antianginal Agents Industry Value Chain
10.2 Antianginal Agents Upstream Market
10.3 Antianginal Agents Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antianginal Agents Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Antianginal Agents Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Distribution Channel
1.3 Global Antianginal Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIANGINAL AGENTS OVERALL MARKET SIZE
2.1 Global Antianginal Agents Market Size: 2021 VS 2028
2.2 Global Antianginal Agents Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antianginal Agents Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antianginal Agents Players in Global Market
3.2 Top Global Antianginal Agents Companies Ranked by Revenue
3.3 Global Antianginal Agents Revenue by Companies
3.4 Global Antianginal Agents Sales by Companies
3.5 Global Antianginal Agents Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antianginal Agents Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antianginal Agents Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antianginal Agents Players in Global Market
3.8.1 List of Global Tier 1 Antianginal Agents Companies
3.8.2 List of Global Tier 2 and Tier 3 Antianginal Agents Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antianginal Agents Market Size Markets, 2021 & 2028
4.1.2 Nitrates
4.1.3 Beta Blockers
4.1.4 Calcium Channel Blockers
4.2 By Type - Global Antianginal Agents Revenue & Forecasts
4.2.1 By Type - Global Antianginal Agents Revenue, 2017-2022
4.2.2 By Type - Global Antianginal Agents Revenue, 2023-2028
4.2.3 By Type - Global Antianginal Agents Revenue Market Share, 2017-2028
4.3 By Type - Global Antianginal Agents Sales & Forecasts
4.3.1 By Type - Global Antianginal Agents Sales, 2017-2022
4.3.2 By Type - Global Antianginal Agents Sales, 2023-2028
4.3.3 By Type - Global Antianginal Agents Sales Market Share, 2017-2028
4.4 By Type - Global Antianginal Agents Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY DISTRIBUTION CHANNEL
5.1 Overview
5.1.1 By Distribution Channel - Global Antianginal Agents Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Distribution Channel - Global Antianginal Agents Revenue & Forecasts
5.2.1 By Distribution Channel - Global Antianginal Agents Revenue, 2017-2022
5.2.2 By Distribution Channel - Global Antianginal Agents Revenue, 2023-2028
5.2.3 By Distribution Channel - Global Antianginal Agents Revenue Market Share, 2017-2028
5.3 By Distribution Channel - Global Antianginal Agents Sales & Forecasts
5.3.1 By Distribution Channel - Global Antianginal Agents Sales, 2017-2022
5.3.2 By Distribution Channel - Global Antianginal Agents Sales, 2023-2028
5.3.3 By Distribution Channel - Global Antianginal Agents Sales Market Share, 2017-2028
5.4 By Distribution Channel - Global Antianginal Agents Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antianginal Agents Market Size, 2021 & 2028
6.2 By Region - Global Antianginal Agents Revenue & Forecasts
6.2.1 By Region - Global Antianginal Agents Revenue, 2017-2022
6.2.2 By Region - Global Antianginal Agents Revenue, 2023-2028
6.2.3 By Region - Global Antianginal Agents Revenue Market Share, 2017-2028
6.3 By Region - Global Antianginal Agents Sales & Forecasts
6.3.1 By Region - Global Antianginal Agents Sales, 2017-2022
6.3.2 By Region - Global Antianginal Agents Sales, 2023-2028
6.3.3 By Region - Global Antianginal Agents Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antianginal Agents Revenue, 2017-2028
6.4.2 By Country - North America Antianginal Agents Sales, 2017-2028
6.4.3 US Antianginal Agents Market Size, 2017-2028
6.4.4 Canada Antianginal Agents Market Size, 2017-2028
6.4.5 Mexico Antianginal Agents Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antianginal Agents Revenue, 2017-2028
6.5.2 By Country - Europe Antianginal Agents Sales, 2017-2028
6.5.3 Germany Antianginal Agents Market Size, 2017-2028
6.5.4 France Antianginal Agents Market Size, 2017-2028
6.5.5 U.K. Antianginal Agents Market Size, 2017-2028
6.5.6 Italy Antianginal Agents Market Size, 2017-2028
6.5.7 Russia Antianginal Agents Market Size, 2017-2028
6.5.8 Nordic Countries Antianginal Agents Market Size, 2017-2028
6.5.9 Benelux Antianginal Agents Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antianginal Agents Revenue, 2017-2028
6.6.2 By Region - Asia Antianginal Agents Sales, 2017-2028
6.6.3 China Antianginal Agents Market Size, 2017-2028
6.6.4 Japan Antianginal Agents Market Size, 2017-2028
6.6.5 South Korea Antianginal Agents Market Size, 2017-2028
6.6.6 Southeast Asia Antianginal Agents Market Size, 2017-2028
6.6.7 India Antianginal Agents Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antianginal Agents Revenue, 2017-2028
6.7.2 By Country - South America Antianginal Agents Sales, 2017-2028
6.7.3 Brazil Antianginal Agents Market Size, 2017-2028
6.7.4 Argentina Antianginal Agents Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antianginal Agents Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antianginal Agents Sales, 2017-2028
6.8.3 Turkey Antianginal Agents Market Size, 2017-2028
6.8.4 Israel Antianginal Agents Market Size, 2017-2028
6.8.5 Saudi Arabia Antianginal Agents Market Size, 2017-2028
6.8.6 UAE Antianginal Agents Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Antianginal Agents Major Product Offerings
7.1.4 Teva Antianginal Agents Sales and Revenue in Global (2017-2022)
7.1.5 Teva Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Antianginal Agents Major Product Offerings
7.2.4 Merck Antianginal Agents Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Antianginal Agents Major Product Offerings
7.3.4 Pfizer Antianginal Agents Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Mylan N.V.
7.4.1 Mylan N.V. Corporate Summary
7.4.2 Mylan N.V. Business Overview
7.4.3 Mylan N.V. Antianginal Agents Major Product Offerings
7.4.4 Mylan N.V. Antianginal Agents Sales and Revenue in Global (2017-2022)
7.4.5 Mylan N.V. Key News
7.5 Elite Pharmaceutical Solution Inc.
7.5.1 Elite Pharmaceutical Solution Inc. Corporate Summary
7.5.2 Elite Pharmaceutical Solution Inc. Business Overview
7.5.3 Elite Pharmaceutical Solution Inc. Antianginal Agents Major Product Offerings
7.5.4 Elite Pharmaceutical Solution Inc. Antianginal Agents Sales and Revenue in Global (2017-2022)
7.5.5 Elite Pharmaceutical Solution Inc. Key News
7.6 Pharmaoffer.com
7.6.1 Pharmaoffer.com Corporate Summary
7.6.2 Pharmaoffer.com Business Overview
7.6.3 Pharmaoffer.com Antianginal Agents Major Product Offerings
7.6.4 Pharmaoffer.com Antianginal Agents Sales and Revenue in Global (2017-2022)
7.6.5 Pharmaoffer.com Key News
7.7 AstraZeneca
7.7.1 AstraZeneca Corporate Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Antianginal Agents Major Product Offerings
7.7.4 AstraZeneca Antianginal Agents Sales and Revenue in Global (2017-2022)
7.7.5 AstraZeneca Key News
7.8 ACETO
7.8.1 ACETO Corporate Summary
7.8.2 ACETO Business Overview
7.8.3 ACETO Antianginal Agents Major Product Offerings
7.8.4 ACETO Antianginal Agents Sales and Revenue in Global (2017-2022)
7.8.5 ACETO Key News
7.9 Nesher Pharmaceuticals
7.9.1 Nesher Pharmaceuticals Corporate Summary
7.9.2 Nesher Pharmaceuticals Business Overview
7.9.3 Nesher Pharmaceuticals Antianginal Agents Major Product Offerings
7.9.4 Nesher Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.9.5 Nesher Pharmaceuticals Key News
7.10 Taj pharmaceutical
7.10.1 Taj pharmaceutical Corporate Summary
7.10.2 Taj pharmaceutical Business Overview
7.10.3 Taj pharmaceutical Antianginal Agents Major Product Offerings
7.10.4 Taj pharmaceutical Antianginal Agents Sales and Revenue in Global (2017-2022)
7.10.5 Taj pharmaceutical Key News
7.11 Espero BioPharma
7.11.1 Espero BioPharma Corporate Summary
7.11.2 Espero BioPharma Antianginal Agents Business Overview
7.11.3 Espero BioPharma Antianginal Agents Major Product Offerings
7.11.4 Espero BioPharma Antianginal Agents Sales and Revenue in Global (2017-2022)
7.11.5 Espero BioPharma Key News
7.12 Hikma Pharmaceuticals
7.12.1 Hikma Pharmaceuticals Corporate Summary
7.12.2 Hikma Pharmaceuticals Antianginal Agents Business Overview
7.12.3 Hikma Pharmaceuticals Antianginal Agents Major Product Offerings
7.12.4 Hikma Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.12.5 Hikma Pharmaceuticals Key News
7.13 Athenex
7.13.1 Athenex Corporate Summary
7.13.2 Athenex Antianginal Agents Business Overview
7.13.3 Athenex Antianginal Agents Major Product Offerings
7.13.4 Athenex Antianginal Agents Sales and Revenue in Global (2017-2022)
7.13.5 Athenex Key News
7.14 Aurobindo Pharma
7.14.1 Aurobindo Pharma Corporate Summary
7.14.2 Aurobindo Pharma Business Overview
7.14.3 Aurobindo Pharma Antianginal Agents Major Product Offerings
7.14.4 Aurobindo Pharma Antianginal Agents Sales and Revenue in Global (2017-2022)
7.14.5 Aurobindo Pharma Key News
7.15 AMRI
7.15.1 AMRI Corporate Summary
7.15.2 AMRI Business Overview
7.15.3 AMRI Antianginal Agents Major Product Offerings
7.15.4 AMRI Antianginal Agents Sales and Revenue in Global (2017-2022)
7.15.5 AMRI Key News
7.16 Intas Pharmaceuticals
7.16.1 Intas Pharmaceuticals Corporate Summary
7.16.2 Intas Pharmaceuticals Business Overview
7.16.3 Intas Pharmaceuticals Antianginal Agents Major Product Offerings
7.16.4 Intas Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.16.5 Intas Pharmaceuticals Key News
7.17 Glenmark Pharmaceuticals
7.17.1 Glenmark Pharmaceuticals Corporate Summary
7.17.2 Glenmark Pharmaceuticals Business Overview
7.17.3 Glenmark Pharmaceuticals Antianginal Agents Major Product Offerings
7.17.4 Glenmark Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.17.5 Glenmark Pharmaceuticals Key News
7.18 Troikaa
7.18.1 Troikaa Corporate Summary
7.18.2 Troikaa Business Overview
7.18.3 Troikaa Antianginal Agents Major Product Offerings
7.18.4 Troikaa Antianginal Agents Sales and Revenue in Global (2017-2022)
7.18.5 Troikaa Key News
7.19 Square Pharmaceuticals
7.19.1 Square Pharmaceuticals Corporate Summary
7.19.2 Square Pharmaceuticals Business Overview
7.19.3 Square Pharmaceuticals Antianginal Agents Major Product Offerings
7.19.4 Square Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.19.5 Square Pharmaceuticals Key News
7.20 Sun Pharmaceutical
7.20.1 Sun Pharmaceutical Corporate Summary
7.20.2 Sun Pharmaceutical Business Overview
7.20.3 Sun Pharmaceutical Antianginal Agents Major Product Offerings
7.20.4 Sun Pharmaceutical Antianginal Agents Sales and Revenue in Global (2017-2022)
7.20.5 Sun Pharmaceutical Key News
7.21 Unique Pharmaceuticals
7.21.1 Unique Pharmaceuticals Corporate Summary
7.21.2 Unique Pharmaceuticals Business Overview
7.21.3 Unique Pharmaceuticals Antianginal Agents Major Product Offerings
7.21.4 Unique Pharmaceuticals Antianginal Agents Sales and Revenue in Global (2017-2022)
7.21.5 Unique Pharmaceuticals Key News
7.22 Ipca Laboratories
7.22.1 Ipca Laboratories Corporate Summary
7.22.2 Ipca Laboratories Business Overview
7.22.3 Ipca Laboratories Antianginal Agents Major Product Offerings
7.22.4 Ipca Laboratories Antianginal Agents Sales and Revenue in Global (2017-2022)
7.22.5 Ipca Laboratories Key News
7.23 Sandoz
7.23.1 Sandoz Corporate Summary
7.23.2 Sandoz Business Overview
7.23.3 Sandoz Antianginal Agents Major Product Offerings
7.23.4 Sandoz Antianginal Agents Sales and Revenue in Global (2017-2022)
7.23.5 Sandoz Key News
7.24 Globus Remedies
7.24.1 Globus Remedies Corporate Summary
7.24.2 Globus Remedies Business Overview
7.24.3 Globus Remedies Antianginal Agents Major Product Offerings
7.24.4 Globus Remedies Antianginal Agents Sales and Revenue in Global (2017-2022)
7.24.5 Globus Remedies Key News
7.25 Shandong Fangming Pharmaceutical Group
7.25.1 Shandong Fangming Pharmaceutical Group Corporate Summary
7.25.2 Shandong Fangming Pharmaceutical Group Business Overview
7.25.3 Shandong Fangming Pharmaceutical Group Antianginal Agents Major Product Offerings
7.25.4 Shandong Fangming Pharmaceutical Group Antianginal Agents Sales and Revenue in Global (2017-2022)
7.25.5 Shandong Fangming Pharmaceutical Group Key News
7.26 ReYoung Pharmaceutical
7.26.1 ReYoung Pharmaceutical Corporate Summary
7.26.2 ReYoung Pharmaceutical Business Overview
7.26.3 ReYoung Pharmaceutical Antianginal Agents Major Product Offerings
7.26.4 ReYoung Pharmaceutical Antianginal Agents Sales and Revenue in Global (2017-2022)
7.26.5 ReYoung Pharmaceutical Key News
8 GLOBAL ANTIANGINAL AGENTS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antianginal Agents Production Capacity, 2017-2028
8.2 Antianginal Agents Production Capacity of Key Manufacturers in Global Market
8.3 Global Antianginal Agents Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIANGINAL AGENTS SUPPLY CHAIN ANALYSIS
10.1 Antianginal Agents Industry Value Chain
10.2 Antianginal Agents Upstream Market
10.3 Antianginal Agents Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antianginal Agents Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Antianginal Agents in Global Market
Table 2. Top Antianginal Agents Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antianginal Agents Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antianginal Agents Revenue Share by Companies, 2017-2022
Table 5. Global Antianginal Agents Sales by Companies, (K Units), 2017-2022
Table 6. Global Antianginal Agents Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antianginal Agents Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Antianginal Agents Product Type
Table 9. List of Global Tier 1 Antianginal Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antianginal Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antianginal Agents Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antianginal Agents Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antianginal Agents Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antianginal Agents Sales (K Units), 2017-2022
Table 15. By Type - Global Antianginal Agents Sales (K Units), 2023-2028
Table 16. By Distribution Channel – Global Antianginal Agents Revenue, (US$, Mn), 2021 & 2028
Table 17. By Distribution Channel - Global Antianginal Agents Revenue (US$, Mn), 2017-2022
Table 18. By Distribution Channel - Global Antianginal Agents Revenue (US$, Mn), 2023-2028
Table 19. By Distribution Channel - Global Antianginal Agents Sales (K Units), 2017-2022
Table 20. By Distribution Channel - Global Antianginal Agents Sales (K Units), 2023-2028
Table 21. By Region – Global Antianginal Agents Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antianginal Agents Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antianginal Agents Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antianginal Agents Sales (K Units), 2017-2022
Table 25. By Region - Global Antianginal Agents Sales (K Units), 2023-2028
Table 26. By Country - North America Antianginal Agents Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antianginal Agents Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antianginal Agents Sales, (K Units), 2017-2022
Table 29. By Country - North America Antianginal Agents Sales, (K Units), 2023-2028
Table 30. By Country - Europe Antianginal Agents Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antianginal Agents Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antianginal Agents Sales, (K Units), 2017-2022
Table 33. By Country - Europe Antianginal Agents Sales, (K Units), 2023-2028
Table 34. By Region - Asia Antianginal Agents Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antianginal Agents Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antianginal Agents Sales, (K Units), 2017-2022
Table 37. By Region - Asia Antianginal Agents Sales, (K Units), 2023-2028
Table 38. By Country - South America Antianginal Agents Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antianginal Agents Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antianginal Agents Sales, (K Units), 2017-2022
Table 41. By Country - South America Antianginal Agents Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Antianginal Agents Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antianginal Agents Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antianginal Agents Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Antianginal Agents Sales, (K Units), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Antianginal Agents Product Offerings
Table 48. Teva Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Antianginal Agents Product Offerings
Table 51. Merck Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Antianginal Agents Product Offerings
Table 54. Pfizer Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Mylan N.V. Corporate Summary
Table 56. Mylan N.V. Antianginal Agents Product Offerings
Table 57. Mylan N.V. Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Elite Pharmaceutical Solution Inc. Corporate Summary
Table 59. Elite Pharmaceutical Solution Inc. Antianginal Agents Product Offerings
Table 60. Elite Pharmaceutical Solution Inc. Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Pharmaoffer.com Corporate Summary
Table 62. Pharmaoffer.com Antianginal Agents Product Offerings
Table 63. Pharmaoffer.com Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. AstraZeneca Corporate Summary
Table 65. AstraZeneca Antianginal Agents Product Offerings
Table 66. AstraZeneca Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. ACETO Corporate Summary
Table 68. ACETO Antianginal Agents Product Offerings
Table 69. ACETO Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Nesher Pharmaceuticals Corporate Summary
Table 71. Nesher Pharmaceuticals Antianginal Agents Product Offerings
Table 72. Nesher Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Taj pharmaceutical Corporate Summary
Table 74. Taj pharmaceutical Antianginal Agents Product Offerings
Table 75. Taj pharmaceutical Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Espero BioPharma Corporate Summary
Table 77. Espero BioPharma Antianginal Agents Product Offerings
Table 78. Espero BioPharma Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Hikma Pharmaceuticals Corporate Summary
Table 80. Hikma Pharmaceuticals Antianginal Agents Product Offerings
Table 81. Hikma Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Athenex Corporate Summary
Table 83. Athenex Antianginal Agents Product Offerings
Table 84. Athenex Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Aurobindo Pharma Corporate Summary
Table 86. Aurobindo Pharma Antianginal Agents Product Offerings
Table 87. Aurobindo Pharma Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. AMRI Corporate Summary
Table 89. AMRI Antianginal Agents Product Offerings
Table 90. AMRI Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Intas Pharmaceuticals Corporate Summary
Table 92. Intas Pharmaceuticals Antianginal Agents Product Offerings
Table 93. Intas Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Glenmark Pharmaceuticals Corporate Summary
Table 95. Glenmark Pharmaceuticals Antianginal Agents Product Offerings
Table 96. Glenmark Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Troikaa Corporate Summary
Table 98. Troikaa Antianginal Agents Product Offerings
Table 99. Troikaa Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Square Pharmaceuticals Corporate Summary
Table 101. Square Pharmaceuticals Antianginal Agents Product Offerings
Table 102. Square Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Sun Pharmaceutical Corporate Summary
Table 104. Sun Pharmaceutical Antianginal Agents Product Offerings
Table 105. Sun Pharmaceutical Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Unique Pharmaceuticals Corporate Summary
Table 107. Unique Pharmaceuticals Antianginal Agents Product Offerings
Table 108. Unique Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. Ipca Laboratories Corporate Summary
Table 110. Ipca Laboratories Antianginal Agents Product Offerings
Table 111. Ipca Laboratories Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Sandoz Corporate Summary
Table 113. Sandoz Antianginal Agents Product Offerings
Table 114. Sandoz Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 115. Globus Remedies Corporate Summary
Table 116. Globus Remedies Antianginal Agents Product Offerings
Table 117. Globus Remedies Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 118. Shandong Fangming Pharmaceutical Group Corporate Summary
Table 119. Shandong Fangming Pharmaceutical Group Antianginal Agents Product Offerings
Table 120. Shandong Fangming Pharmaceutical Group Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 121. ReYoung Pharmaceutical Corporate Summary
Table 122. ReYoung Pharmaceutical Antianginal Agents Product Offerings
Table 123. ReYoung Pharmaceutical Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 124. Antianginal Agents Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 125. Global Antianginal Agents Capacity Market Share of Key Manufacturers, 2020-2022
Table 126. Global Antianginal Agents Production by Region, 2017-2022 (K Units)
Table 127. Global Antianginal Agents Production by Region, 2023-2028 (K Units)
Table 128. Antianginal Agents Market Opportunities & Trends in Global Market
Table 129. Antianginal Agents Market Drivers in Global Market
Table 130. Antianginal Agents Market Restraints in Global Market
Table 131. Antianginal Agents Raw Materials
Table 132. Antianginal Agents Raw Materials Suppliers in Global Market
Table 133. Typical Antianginal Agents Downstream
Table 134. Antianginal Agents Downstream Clients in Global Market
Table 135. Antianginal Agents Distributors and Sales Agents in Global Market
Table 1. Key Players of Antianginal Agents in Global Market
Table 2. Top Antianginal Agents Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antianginal Agents Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antianginal Agents Revenue Share by Companies, 2017-2022
Table 5. Global Antianginal Agents Sales by Companies, (K Units), 2017-2022
Table 6. Global Antianginal Agents Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antianginal Agents Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Antianginal Agents Product Type
Table 9. List of Global Tier 1 Antianginal Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antianginal Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antianginal Agents Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antianginal Agents Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antianginal Agents Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antianginal Agents Sales (K Units), 2017-2022
Table 15. By Type - Global Antianginal Agents Sales (K Units), 2023-2028
Table 16. By Distribution Channel – Global Antianginal Agents Revenue, (US$, Mn), 2021 & 2028
Table 17. By Distribution Channel - Global Antianginal Agents Revenue (US$, Mn), 2017-2022
Table 18. By Distribution Channel - Global Antianginal Agents Revenue (US$, Mn), 2023-2028
Table 19. By Distribution Channel - Global Antianginal Agents Sales (K Units), 2017-2022
Table 20. By Distribution Channel - Global Antianginal Agents Sales (K Units), 2023-2028
Table 21. By Region – Global Antianginal Agents Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antianginal Agents Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antianginal Agents Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antianginal Agents Sales (K Units), 2017-2022
Table 25. By Region - Global Antianginal Agents Sales (K Units), 2023-2028
Table 26. By Country - North America Antianginal Agents Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antianginal Agents Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antianginal Agents Sales, (K Units), 2017-2022
Table 29. By Country - North America Antianginal Agents Sales, (K Units), 2023-2028
Table 30. By Country - Europe Antianginal Agents Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antianginal Agents Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antianginal Agents Sales, (K Units), 2017-2022
Table 33. By Country - Europe Antianginal Agents Sales, (K Units), 2023-2028
Table 34. By Region - Asia Antianginal Agents Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antianginal Agents Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antianginal Agents Sales, (K Units), 2017-2022
Table 37. By Region - Asia Antianginal Agents Sales, (K Units), 2023-2028
Table 38. By Country - South America Antianginal Agents Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antianginal Agents Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antianginal Agents Sales, (K Units), 2017-2022
Table 41. By Country - South America Antianginal Agents Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Antianginal Agents Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antianginal Agents Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antianginal Agents Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Antianginal Agents Sales, (K Units), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Antianginal Agents Product Offerings
Table 48. Teva Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Antianginal Agents Product Offerings
Table 51. Merck Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Antianginal Agents Product Offerings
Table 54. Pfizer Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Mylan N.V. Corporate Summary
Table 56. Mylan N.V. Antianginal Agents Product Offerings
Table 57. Mylan N.V. Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Elite Pharmaceutical Solution Inc. Corporate Summary
Table 59. Elite Pharmaceutical Solution Inc. Antianginal Agents Product Offerings
Table 60. Elite Pharmaceutical Solution Inc. Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Pharmaoffer.com Corporate Summary
Table 62. Pharmaoffer.com Antianginal Agents Product Offerings
Table 63. Pharmaoffer.com Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. AstraZeneca Corporate Summary
Table 65. AstraZeneca Antianginal Agents Product Offerings
Table 66. AstraZeneca Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. ACETO Corporate Summary
Table 68. ACETO Antianginal Agents Product Offerings
Table 69. ACETO Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Nesher Pharmaceuticals Corporate Summary
Table 71. Nesher Pharmaceuticals Antianginal Agents Product Offerings
Table 72. Nesher Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Taj pharmaceutical Corporate Summary
Table 74. Taj pharmaceutical Antianginal Agents Product Offerings
Table 75. Taj pharmaceutical Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Espero BioPharma Corporate Summary
Table 77. Espero BioPharma Antianginal Agents Product Offerings
Table 78. Espero BioPharma Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Hikma Pharmaceuticals Corporate Summary
Table 80. Hikma Pharmaceuticals Antianginal Agents Product Offerings
Table 81. Hikma Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Athenex Corporate Summary
Table 83. Athenex Antianginal Agents Product Offerings
Table 84. Athenex Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Aurobindo Pharma Corporate Summary
Table 86. Aurobindo Pharma Antianginal Agents Product Offerings
Table 87. Aurobindo Pharma Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. AMRI Corporate Summary
Table 89. AMRI Antianginal Agents Product Offerings
Table 90. AMRI Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Intas Pharmaceuticals Corporate Summary
Table 92. Intas Pharmaceuticals Antianginal Agents Product Offerings
Table 93. Intas Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Glenmark Pharmaceuticals Corporate Summary
Table 95. Glenmark Pharmaceuticals Antianginal Agents Product Offerings
Table 96. Glenmark Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Troikaa Corporate Summary
Table 98. Troikaa Antianginal Agents Product Offerings
Table 99. Troikaa Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Square Pharmaceuticals Corporate Summary
Table 101. Square Pharmaceuticals Antianginal Agents Product Offerings
Table 102. Square Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Sun Pharmaceutical Corporate Summary
Table 104. Sun Pharmaceutical Antianginal Agents Product Offerings
Table 105. Sun Pharmaceutical Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Unique Pharmaceuticals Corporate Summary
Table 107. Unique Pharmaceuticals Antianginal Agents Product Offerings
Table 108. Unique Pharmaceuticals Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. Ipca Laboratories Corporate Summary
Table 110. Ipca Laboratories Antianginal Agents Product Offerings
Table 111. Ipca Laboratories Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Sandoz Corporate Summary
Table 113. Sandoz Antianginal Agents Product Offerings
Table 114. Sandoz Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 115. Globus Remedies Corporate Summary
Table 116. Globus Remedies Antianginal Agents Product Offerings
Table 117. Globus Remedies Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 118. Shandong Fangming Pharmaceutical Group Corporate Summary
Table 119. Shandong Fangming Pharmaceutical Group Antianginal Agents Product Offerings
Table 120. Shandong Fangming Pharmaceutical Group Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 121. ReYoung Pharmaceutical Corporate Summary
Table 122. ReYoung Pharmaceutical Antianginal Agents Product Offerings
Table 123. ReYoung Pharmaceutical Antianginal Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 124. Antianginal Agents Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 125. Global Antianginal Agents Capacity Market Share of Key Manufacturers, 2020-2022
Table 126. Global Antianginal Agents Production by Region, 2017-2022 (K Units)
Table 127. Global Antianginal Agents Production by Region, 2023-2028 (K Units)
Table 128. Antianginal Agents Market Opportunities & Trends in Global Market
Table 129. Antianginal Agents Market Drivers in Global Market
Table 130. Antianginal Agents Market Restraints in Global Market
Table 131. Antianginal Agents Raw Materials
Table 132. Antianginal Agents Raw Materials Suppliers in Global Market
Table 133. Typical Antianginal Agents Downstream
Table 134. Antianginal Agents Downstream Clients in Global Market
Table 135. Antianginal Agents Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Antianginal Agents Segment by Type
Figure 2. Antianginal Agents Segment by Distribution Channel
Figure 3. Global Antianginal Agents Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antianginal Agents Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antianginal Agents Revenue, 2017-2028 (US$, Mn)
Figure 7. Antianginal Agents Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antianginal Agents Revenue in 2021
Figure 9. By Type - Global Antianginal Agents Sales Market Share, 2017-2028
Figure 10. By Type - Global Antianginal Agents Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antianginal Agents Price (US$/Unit), 2017-2028
Figure 12. By Distribution Channel - Global Antianginal Agents Sales Market Share, 2017-2028
Figure 13. By Distribution Channel - Global Antianginal Agents Revenue Market Share, 2017-2028
Figure 14. By Distribution Channel - Global Antianginal Agents Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Antianginal Agents Sales Market Share, 2017-2028
Figure 16. By Region - Global Antianginal Agents Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antianginal Agents Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antianginal Agents Sales Market Share, 2017-2028
Figure 19. US Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antianginal Agents Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antianginal Agents Sales Market Share, 2017-2028
Figure 24. Germany Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 25. France Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antianginal Agents Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antianginal Agents Sales Market Share, 2017-2028
Figure 33. China Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 37. India Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antianginal Agents Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antianginal Agents Sales Market Share, 2017-2028
Figure 40. Brazil Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antianginal Agents Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antianginal Agents Sales Market Share, 2017-2028
Figure 44. Turkey Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antianginal Agents Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Antianginal Agents by Region, 2021 VS 2028
Figure 50. Antianginal Agents Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Antianginal Agents Segment by Type
Figure 2. Antianginal Agents Segment by Distribution Channel
Figure 3. Global Antianginal Agents Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antianginal Agents Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antianginal Agents Revenue, 2017-2028 (US$, Mn)
Figure 7. Antianginal Agents Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antianginal Agents Revenue in 2021
Figure 9. By Type - Global Antianginal Agents Sales Market Share, 2017-2028
Figure 10. By Type - Global Antianginal Agents Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antianginal Agents Price (US$/Unit), 2017-2028
Figure 12. By Distribution Channel - Global Antianginal Agents Sales Market Share, 2017-2028
Figure 13. By Distribution Channel - Global Antianginal Agents Revenue Market Share, 2017-2028
Figure 14. By Distribution Channel - Global Antianginal Agents Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Antianginal Agents Sales Market Share, 2017-2028
Figure 16. By Region - Global Antianginal Agents Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antianginal Agents Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antianginal Agents Sales Market Share, 2017-2028
Figure 19. US Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antianginal Agents Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antianginal Agents Sales Market Share, 2017-2028
Figure 24. Germany Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 25. France Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antianginal Agents Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antianginal Agents Sales Market Share, 2017-2028
Figure 33. China Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 37. India Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antianginal Agents Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antianginal Agents Sales Market Share, 2017-2028
Figure 40. Brazil Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antianginal Agents Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antianginal Agents Sales Market Share, 2017-2028
Figure 44. Turkey Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antianginal Agents Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antianginal Agents Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Antianginal Agents by Region, 2021 VS 2028
Figure 50. Antianginal Agents Industry Value Chain
Figure 51. Marketing Channels
